Adam Ard, Carlos Cruz-Cortés, Xinmin Gan, Guadalupe Guerrero-Serna, Andrew D. White, Martin C. Clasby, L. Michel Espinoza-Fonseca
{"title":"对“sar引导的小分子SERCA2a激活剂的开发:发现心血管应用的强效吲哚,苯并呋喃和苯二唑类似物”的更正","authors":"Adam Ard, Carlos Cruz-Cortés, Xinmin Gan, Guadalupe Guerrero-Serna, Andrew D. White, Martin C. Clasby, L. Michel Espinoza-Fonseca","doi":"10.1021/acs.jmedchem.5c02878","DOIUrl":null,"url":null,"abstract":"Due to a production error, several graphics are missing from the PDF version of this paper. The complete PDF is included here as Supporting Information. The HTML version is complete. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02878. Complete PDF (PDF) Correction\nto “SAR-Guided Development of Small-Molecule\nSERCA2a Activators: Discovery of Potent Indoline, Benzofuran, and\nBenzodioxole Analogs for Cardiovascular Applications” <span> 2 </span><span> views </span> <span> 0 </span><span> shares </span> <span> 0 </span><span> downloads </span> Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html. This article has not yet been cited by other publications.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"72 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to “SAR-Guided Development of Small-Molecule SERCA2a Activators: Discovery of Potent Indoline, Benzofuran, and Benzodioxole Analogs for Cardiovascular Applications”\",\"authors\":\"Adam Ard, Carlos Cruz-Cortés, Xinmin Gan, Guadalupe Guerrero-Serna, Andrew D. White, Martin C. Clasby, L. Michel Espinoza-Fonseca\",\"doi\":\"10.1021/acs.jmedchem.5c02878\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Due to a production error, several graphics are missing from the PDF version of this paper. The complete PDF is included here as Supporting Information. The HTML version is complete. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02878. Complete PDF (PDF) Correction\\nto “SAR-Guided Development of Small-Molecule\\nSERCA2a Activators: Discovery of Potent Indoline, Benzofuran, and\\nBenzodioxole Analogs for Cardiovascular Applications” <span> 2 </span><span> views </span> <span> 0 </span><span> shares </span> <span> 0 </span><span> downloads </span> Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html. This article has not yet been cited by other publications.\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"72 1\",\"pages\":\"\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acs.jmedchem.5c02878\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.5c02878","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Correction to “SAR-Guided Development of Small-Molecule SERCA2a Activators: Discovery of Potent Indoline, Benzofuran, and Benzodioxole Analogs for Cardiovascular Applications”
Due to a production error, several graphics are missing from the PDF version of this paper. The complete PDF is included here as Supporting Information. The HTML version is complete. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02878. Complete PDF (PDF) Correction
to “SAR-Guided Development of Small-Molecule
SERCA2a Activators: Discovery of Potent Indoline, Benzofuran, and
Benzodioxole Analogs for Cardiovascular Applications” 2 views 0 shares 0 downloads Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html. This article has not yet been cited by other publications.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.